Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 248 pseudogene (ENSG00000248452) is classified as a pseudogene related to the zinc finger protein 248 gene, which encodes a member of the C2H2-type zinc finger protein family. Unlike protein-coding members of this family—such as ZNF248, which is predicted to be involved in transcriptional regulation[1][7][4]—the pseudogene does not code for a functional protein and has no established biological activity or clinical significance. Pseudogenes like this may result from gene duplication or mutation events and are generally transcriptionally and translationally inactive. Protein-coding zinc finger family members are the largest class of transcription factors in humans, broadly involved in DNA binding and gene regulation[3][5][8]. However, *pseudogenes* of these proteins, like zinc finger protein 248 pseudogene, lack the necessary sequences to be translated into functional proteins and are not considered drug targets nor implicated directly in disease or therapy response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 248 pseudogene.